Developments in Gastric Cancer Screening in Europe
The current state of play: Gastric Cancer in Europe In 2020, gastric cancer stood as the 6th most commonly diagnosed cancer, with 136,000 new cases diagnosed in Europe…
Page 34
The current state of play: Gastric Cancer in Europe In 2020, gastric cancer stood as the 6th most commonly diagnosed cancer, with 136,000 new cases diagnosed in Europe…
Ask the Expert with Professor Carel Le Roux – Transforming the Obesity Landscape A leading clinical scientist and expert on how the gut and brain communicate, Professor Carel…
Introduction: Psoriasis is a chronic multisystem autoimmune disease with cutaneous involvement. It is characterised by the rapid growth of skin cells, leading to the formation of thick, red,…
APPEL (Affiliation for Pharmacy Practice Experiential Learning) is now seeking expressions of interest from pharmacists in community and hospital pharmacy settings who would like to facilitate an experiential learning placement for…
Sterile Drug Product Facility receives planning permission at Cruiserath Campus Site, creating 350 jobs by 2026 Bristol Myers Squibb today formally announces the investment $400 million at its…
Hospital Professional News, a leading specialist publishing agency with over 9 years of experience, is proud to announce the launch of the Hospital Professional Honours 2024. This prestigious…
Introduction: Multiple myeloma (MM) is a haematological malignancy characterised by the clonal expansion of malignant plasma cells in the bone marrow. MM manifests clinically as hypercalcaemia, renal failure,…
In October 2023, the 16th European Nursing of Oncology Society’s Conference (EONS16), ‘Cancer nursing: Building on innovation and building back better in healthcare’ took place in Madrid. The…
Pancreatic Cancer: A Tough Nut to Crack! Pancreatic cancer presents a significant clinical challenge. Currently, the 5-year survival rate for patients diagnosed with this cancer is only 12%,…
Introduction to Homologous Recombination Deficiency Homologous recombination deficiency (HRD) represents a pivotal concept in oncology, characterized by a functional loss in the homologous recombination repair (HRR) pathway. Essential…
You’re all caught up.